The Life Sciences Report

Experience, Creativity And Dedication To Finding And Presenting The Best Investment Ideas
Contributor's Links: The Life Sciences Report

The Life Sciences Report features leading investment coverage of the life sciences sector, including biotechnology, pharmaceuticals, tools & diagnostics, and medical devices. A Streetwise Reports publication. 

The Streetwise Reports Team combines experience, creativity and ... more

Following: 17 Followers: 2400

ALL CONTRIBUTIONS

Oil Breaking Out, But The Money Is Elsewhere
Monday, October 9, 2017 11:07 PM EDT
One resource industry dwarfs the rest of them put together: energy.
Read
Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection
Thursday, August 17, 2017 1:17 PM EDT
Inovio Pharmaceuticals Inc. exited Q2/17 with $92 million in cash. It has closed a public offering that yielded $70.5 million, which "would be used for general corporate purposes, including clinical trial expenses.
In this article: INO
Read
HIV Vaccine Clinical Study Results In High Immune Response Rates In Healthy Subjects
Wednesday, June 7, 2017 12:01 PM EDT
A clinical study of an HIV vaccine in healthy subjects that found a nearly 100% immune response rate was hailed by a pair of industry analysts. Inovio Pharmaceuticals Inc. has a "buy" rating.
In this article: INO Also: GILD
Read
RXi Pharmaceuticals Receives Japanese Patent For RNAi Platform
Thursday, April 13, 2017 1:17 PM EDT
With the granting of a new patent in Japan for its lead compound, RXI-109, RXI Pharmaceuticals has strengthened its reach in Asian markets and enhanced the protections surrounding its proprietary RNAi platform.
In this article: RXII
Read
Regeneus Hits The Fast Track With Major Japanese Partnership
Thursday, February 9, 2017 1:57 PM EDT
Regeneus, an Australian company, has entered into an collaboration with a major Japanese firm to manufacture its stem cell therapy Progenza, a move that may accelerate approval and that has a pair of analysts optimistic about the company's future.
In this article: ASGLY, FUJIY, SSDOY, TKPYY
Read
OncoSec Delivers Cancer Therapy Straight To The Tumor
Monday, June 6, 2016 3:00 PM EDT
OncoSec Medical Incorporated's Punit Dhillon describes how his company is challenging that paradigm with a proprietary platform that delivers therapeutic agents directly to the tumor...
In this article: ONCS
Read
All Posts

STOCKS I FOLLOW

ABBV AbbVie Inc.
ABT Abbott Laboratories
ACAD ACADIA Pharmaceuticals Inc.
ACFN Acorn Energy Inc.
ACHN Achillion Pharmaceuticals Inc.
ACOR Acorda Therapeutics, Inc.
ACRX AcelRx Pharmaceuticals Inc.
ACTC ADVANCED CELL TECH
ADDXF ADDEX PHARMA ORD
ALPMF ASTELLAS PHARMA INC
AMBS Amarantus Bioscience Holdings Inc
APRI Apricus Biosciences, Inc
ARIA ARIAD Pharmaceuticals Inc.
ARNA Arena Pharmaceuticals, Inc.
Load More

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications

The Life Sciences Report
Streetwise Reports

Focused on biotechnology, pharmaceuticals, medical devices, tools and diagnostics.